ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Aileron Therapeutics Inc

Aileron Therapeutics Inc (ALRN)

3.83
0.00
(0.00%)
Closed November 13 4:00PM
0.00
0.00
(0.00%)

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.83
Bid
3.59
Ask
3.83
Volume
-
0.00 Day's Range 0.00
1.52 52 Week Range 7.42
Market Cap
Previous Close
3.83
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
72,893
Shares Outstanding
21,665,799
Dividend Yield
-
PE Ratio
-5.27
Earnings Per Share (EPS)
-0.73
Revenue
-
Net Profit
-15.73M

About Aileron Therapeutics Inc

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Aileron Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALRN. The last closing price for Aileron Therapeutics was $3.83. Over the last year, Aileron Therapeutics shares have traded in a share price range of $ 1.52 to $ 7.42.

Aileron Therapeutics currently has 21,665,799 shares outstanding. The market capitalization of Aileron Therapeutics is $82.98 million. Aileron Therapeutics has a price to earnings ratio (PE ratio) of -5.27.

ALRN Latest News

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma PR Newswire AUSTIN, Texas and NEW YORK, Oct. 31, 2024...

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium...

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) PR Newswire AUSTIN, Texas, Sept. 23, 2024...

Aileron Therapeutics to Present at the 8th Annual IPF Summit

Aileron Therapeutics to Present at the 8th Annual IPF Summit PR Newswire AUSTIN, Texas, Aug. 19, 2024 AUSTIN, Texas, Aug. 19, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:...

Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights PR Newswire AUSTIN, Texas, Aug. 14, 2024 Announced positive data from Cohort 1 of the ongoing Phase 1b...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-4.010025062663.993.993.55293213.73753029CS
40.236.388888888893.64.43.32810683.8284654CS
121.4359.58333333332.44.42.2728933.38136107CS
260.020.5249343832023.814.41.61686523.14417446CS
522.05115.1685393261.787.421.52842723.91882814CS
156-13.67-78.114285714317.517.638021.012396696.18137919CS
260-6.77-63.867924528310.649.41.0159356123.25130472CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 13.91
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.61
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.17
(0.00%)
0
AACGATA Creativity Global
$ 1.03
(0.00%)
0
AALAmerican Airlines Group Inc
$ 13.91
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.61
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.17
(0.00%)
0
AACGATA Creativity Global
$ 1.03
(0.00%)
0
AALAmerican Airlines Group Inc
$ 13.91
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 65.61
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.17
(0.00%)
0
AACGATA Creativity Global
$ 1.03
(0.00%)
0

Discussion

View Full Feed
No Posts Found

Your Recent History

Delayed Upgrade Clock